Evaluation of fetal myocardial performance index in gestational diabetes mellitus
Congenital Anomalies · 2023
DOI: 10.1111/cga.12531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Congenital Anomalies, 2023. Verfasst von Merve Ozturk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, Turkish Ministry of Health, Ankara City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Diabetes, Gestational, Insulins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study aimed to compare fetal myocardial performance index (MPI) between fetuses of pregnant women with gestational diabetes mellitus (GDM) and healthy controls and to evaluate the relationship between MPI and maternal glucose levels. This was a prospective study of 90 pregnant women, including 50 pregnancies with GDM (27 pregnancies with insulin‐regulated GDM and 23 pregnancies with diet‐regulated GDM) and 40 healthy controls. Isovolumetric contraction time (ICT) + isovolumetric relaxation time (IRT)/ejection time (ET) were used to calculate the MPI (MPI = [ICT + IRT]/ET). Fetal MPI, PR interval, E/A ratio, maternal plasma glucose levels on the day of MPI measurement, and neonatal outcomes were compared. The fetal left‐MPI was significantly higher in the GDM group than healthy controls (0.43 ± 0.04 vs. 0.40 ± 0.06, p = 0.007). The best cut‐off level for MPI was >0.41 to predict adverse perinatal outcomes (sensitivity: 70%, specificity: 68%, area under the curve: 0.715, 95% confidence interval: 0.5143–0.8205, p < 0.001). The fetal MPI values showed no correlation with maternal plasma fasting, postprandial glucose, and hemoglobin A1c (HbA1c) levels. Reduced E/A ratio, higher neonatal intensive care unit admissions, and the need for cesarean delivery were detected in the GDM group. Fetal MPI is impaired in women with GDM, and the need for insulin therapy is associated with higher MPI values and adverse neonatal outcomes. Fetal MPI can help detect fetuses with potential adverse outcome risks, owing to impaired fetal cardiac function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Perinatology, Turkish Ministry of Health, Ankara City Hospital, Ankara, Turkey.
- Department of Perinatology, Etlik Zubeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
ORCID-Profile: Merve Ozturk
Zitieren
APA
Ozturk, M., Agaoglu, Z., Ozturk, F. H., Yakut, K., Öcal, F. D., Oguz, Y., & Caglar, T. (2023). Evaluation of fetal myocardial performance index in gestational diabetes mellitus. Congenital Anomalies. https://doi.org/10.1111/cga.12531
Vancouver
Ozturk M, Agaoglu Z, Ozturk FH, Yakut K, Öcal FD, Oguz Y, et al. Evaluation of fetal myocardial performance index in gestational diabetes mellitus. Congenital Anomalies. 2023. doi:10.1111/cga.12531
BibTeX
@article{Ozturk2023,
author = {Ozturk, Merve and Agaoglu, Zahid and Ozturk, Filiz Halici and Yakut, Kadriye and Öcal, Fatma Doğa and Oguz, Yuksel and Caglar, Turhan},
title = {Evaluation of fetal myocardial performance index in gestational diabetes mellitus},
journal = {Congenital Anomalies},
year = {2023},
doi = {10.1111/cga.12531}
}
EUVIMED